|
104 |
Diverse molecular targets for therapeutic strategies in Alzheimer's disease. Han SH, Mook-Jung I. J Korean Med Sci. 2014 Jul;29(7):893-902. doi: 10.3346/jkms.2014.29.7.893. Epub 2014 Jul 11. |
Link |
|
103 |
Inhibition of Glutaminyl Cyclase Ameliorates Amyloid Pathology in an Animal Model of Alzheimer's Disease via the Modulation of γ-Secretase Activity. Song H, Chang YJ, Moon M, Park SK, Tran PT, Hoang VH, Lee J, Mook-Jung I. J Alzheimers Dis. 2014 Aug 11. [Epub ahead of print] |
Link |
|
102 |
CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease. Byun J, Son SM, Cha MY, Shong M, Hwang YJ, Kim Y, Ryu H, Moon M, Kim KS, Mook-Jung I. Cell Death Differ. 2014 Nov 7. doi: 10.1038/cdd.2014.184. [Epub ahead of print] |
Link |
|
101 |
Disruption of blood-brain barrier in Alzheimer disease pathogenesis. Kook SY, Seok Hong H, Moon M, Mook-Jung I. Tissue Barriers. Apr 1;1(2):e23993. |
Link |
|
100 |
Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Lee S, Lee HC, Kwon YW, Lee SE, Cho Y, Kim J, Lee S, Kim JY, Lee J, Yang HM, Mook-Jung I, Nam KY, Chung J, Lazar MA, Kim HS. Cell Metab. Mar 4;19(3):484-97. |
Link |
|
99 |
Impaired Hippocampal Neurogenesis and its Enhancement with Ghrelin in 5XFAD Mice. Moon M, Cha MY, Mook-Jung I. J Alzheimers Dis. 2014;41(1):233-41 |
Link |
|
98 |
High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice. Kook SY, Lee KM, Kim Y, Cha MY, Kang S, Baik SH, Lee H, Park R, Mook-Jung I. Cell Death Dis. Feb 27;5:e1083. |
Link |
|
97 |
Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Baik SH, Cha MY, Hyun YM, Cho H, Hamza B, Kim DK, Han SH, Choi H, Kim KH, Moon M, Lee J, Kim M, Irimia D, Mook-Jung I. Neurobiol Aging. Jun;35(6):1286-92. |
Link |
|
96 |
Both targeted mass spectrometry and flow sorting analysis methods detected the decreased serum apolipoprotein e level in Alzheimer's disease patients. Han SH, Kim JS, Lee Y, Choi H, Kim JW, Na DL, Yang EG, Yu MH, Hwang D, Lee C, Mook-Jung I. Mol Cell Proteomics. Feb;13(2):407-19. |
Link |
|
95 |
Mitochondrial dysfunction and calcium deregulation by the RanBP9-cofilin pathway. Roh SE, Woo JA, Lakshmana MK, Uhlar C, Ankala V, Boggess T, Liu T, Hong YH, Mook-Jung I, Kim SJ, Kang DE. FASEB J. 2013 Aug 27. |
Link |
